Fulcrum Therapeutics' promising treatment for Sickle Cell Disease and their strong financial position, despite setbacks.
Analysts at US Capital Advisors lifted their Q1 2025 earnings estimates for shares of Western Midstream Partners in a ...
US Capital Advisors upped their Q4 2024 earnings per share estimates for shares of Energy Transfer in a report released on Monday, February 3rd. US Capital Advisors analyst J. Carreker now expects ...
A handful of North Baltimore residents have waged a campaign to stop Baltimore Gas & Electric Co. from coming into a ...
According to Aucello, while cost varies depending on certain factors, building a limited-service hotel in Hawaii could range ...
ET's fourth-quarter earnings are likely to have benefited from its fee-based contracts and contributions from its assets spread across major production basins.
Hosted on MSN10h
Wall Street Analysts Thought Merck Stock Had 10% Downside Risk Heading Into Earnings. That Materialized, So What’s Next?Merck & Co. (NYSE:MRK) is a prominent American multinational pharmaceutical company many investors know for its brand-name ...
Prime Minister Justin Trudeau says U.S. President Donald Trump isn’t joking – he believes Trump’s threat to make Canada the ...
Dii Desert Energy, an energy transition think tank, has reported the Middle East and North Africa (MENA) region will have a cumulative solar capacity of 75 GW at the end of the decade if the current ...
A sharp cut in revenue growth guidance, margin contraction, and rising debt has weighed on NCC shares. While the order pipeline remains strong, payment delays and a stretched working capital cycle ...
Canada-based energy infrastructure firm AltaGas and pipeline operator Keyera entered into long-term agreements for processing ...
The Trace reports on the ATF's recommendation to the police to stop reselling their used guns less than a year after an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback